NewsAmgen "neutral," target price raised
09.07.07 - Credit Suisse
NEW YORK, July 9 (newratings.com) - Analysts at Credit Suisse reiterate their "neutral" rating on Amgen Inc (AMGN). The target price has been raised from $52 to $53.
Share Empfehlen Sie diesen Artikel einem Freund!
AMGN zu meinen Aktien hinzufügen und E-Mail Alerts auf Amgen abonnieren